Literature DB >> 16680023

The unique role of apolipoprotein A-I in HDL remodeling and metabolism.

Henry J Pownall, Christian Ehnholm.   

Abstract

PURPOSE OF REVIEW: To rationalize the distinctive biological behavior of apolipoprotein (apo)A-I and apoA-II in light of differences in their respective structures, properties, and physico-chemical behavior. RECENT
FINDINGS: The distinctive metabolic behavior of apoA-I compared with that of apoA-II, which are revealed as differences in their interactions with the HDL receptor, scavenger receptor class B type I, can be understood in terms of their physico-chemical properties. Detergent and chaotropic perturbation of HDL unmasks properties that distinguish apoA-I from apoA-II and emulate the secondary effects of lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein, and phospholipid transfer protein - the key protein factors in HDL remodeling, that is, formation of lipid-free apoA-I but not apoA-II and particle fusion. Thus, of the two major HDL apolipoproteins, apoA-I is the more plastic and labile and this difference gives apoA-I a unique physiological role that has been verified in mouse models of HDL metabolism.
SUMMARY: The compositions, structures, and properties of HDL particles are important determinants of the mechanisms by which these antiatherogenic lipoproteins are metabolized. Although the plasma lipid transfer proteins and lipid-modifying enzymes are important determinants of HDL processing, the distinctive structures and properties of apoA-I and apoA-II, the two major HDL proteins, determine in different ways the thermodynamic stability of HDL - the former through its greater plasticity and the latter by its higher lipophilicity. These distinctions have been revealed by physico-chemical studies of HDL stability in the context of numerous studies of enzyme and lipid transfer activities and of the interaction of HDL with its hepatic scavenger receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680023     DOI: 10.1097/01.mol.0000226110.66942.e8

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  20 in total

1.  Enhanced binding of apolipoprotein A-I variants associated with hypertriglyceridemia to triglyceride-rich particles.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  Biochemistry       Date:  2011-02-20       Impact factor: 3.162

2.  Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.

Authors:  Amar A Sethi; John A Stonik; Fairwell Thomas; Steve J Demosky; Marcelo Amar; Edward Neufeld; H Bryan Brewer; W Sean Davidson; Wilissa D'Souza; Dmitri Sviridov; Alan T Remaley
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

Review 3.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

Review 4.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

5.  Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

6.  A high throughput serum paraoxonase assay for discovery of small molecule modulators of PON1 activity.

Authors:  Tiffany L Graves; John E Scott
Journal:  Curr Chem Genomics       Date:  2008-11-26

Review 7.  The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Authors:  Harry S Courtney; Henry J Pownall
Journal:  J Biomed Biotechnol       Date:  2010-07-08

8.  The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Authors:  Robert Block; James Corsetti; Ilan Goldenberg; Gabriel Vorobiof; Scott McNitt; Daniel Ryan; Wojciech Zareba; Arthur J Moss
Journal:  Heart Int       Date:  2009-06-30

9.  Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.

Authors:  Sissel Lund-Katz; David Nguyen; Padmaja Dhanasekaran; Momoe Kono; Margaret Nickel; Hiroyuki Saito; Michael C Phillips
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

Review 10.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.